Downregulation of high mobility group box 1 modulates telomere homeostasis and increases the radiosensitivity of human breast cancer cells

Ke,Shaobo; Zhou,Fuxiang; Yang,Hui; Wei,Yuehua; Gong,Jun; Mei,Zijie; Wu,Lin; Yu,Haijun; Zhou,Yunfeng

doi:10.3892/ijo.2014.2793

Downregulation of high mobility group box 1 modulates telomere homeostasis and increases the radiosensitivity of human breast cancer cells

Authors:
- Shaobo Ke
- Fuxiang Zhou
- Hui Yang
- Yuehua Wei
- Jun Gong
- Zijie Mei
- Lin Wu
- Haijun Yu
- Yunfeng Zhou
View Affiliations

Affiliations: Hubei Key Laboratory of Tumor Biological Behavior, Hubei Cancer Clinical Study Center, Zhongnan Hospital, Wuhan University, Wuhan, P.R. China
Published online on: December 10, 2014 https://doi.org/10.3892/ijo.2014.2793
Pages: 1051-1058

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The functions of the high mobility group box 1 (HMGB1) in tumor cells include replenishing telomeric DNA and maintaining cell immortality. There is a negative correlation between human telomerase reverse transcriptase (hTERT) and radiosensitivity in tumor cells. Our aim was to elucidate the relationship among HMGB1, telomere homeostasis and radiosensitivity in MCF-7 cells. In this study, we established stably transfected control (MCF-7-NC) and HMGB1 knockdown (MCF-7-shHMGB1) cell lines. The expression of HMGB1 mRNA and the relative telomere length were examined by real-time PCR. Radiosensitivity was detected by clonogenic assay. The protein expressions were determined by western blot analysis. The telomerase activity was detected by PCR-ELISA. Proliferation ability was examined by CCK-8 assay. Cell cycle and apoptosis were examined by flow cytometry. DNA damage foci were detected by immunofluorescence. ShRNA-mediated downregulation of HMGB1 expression increased the radiosensitivity of MCF-7 cells, and reduced the accumulation of hTERT and cyclin D1. Moreover, knockdown of HMGB1 in MCF-7 cells inhibited telomerase activity and cell proliferation, while increasing the extent of apoptosis. Downregulation of HMGB1 modulated telomere homeostasis by changing the level of telomere-binding proteins, such as TPP1 (PTOP), TRF1 and TRF2. This downregulation also inhibited the ATM and ATR signaling pathways. The current data demonstrate that knockdown of HMGB1 breaks telomere homeostasis, enhances radiosensitivity, and suppresses the repair of DNA damage in human breast cancer cells. These results suggested that HMGB1 might be a potential radiotherapy target in human breast cancer.

View Figures

View References

1	Agresti A and Bianchi ME: HMGB proteins and gene expression. Curr Opin Genet Dev. 13:170–178. 2003. View Article : Google Scholar : PubMed/NCBI
2	Muller S, Scaffidi P, Degryse B, et al: New EMBO members’ review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J. 20:4337–4340. 2001. View Article : Google Scholar
3	Lotze MT and Tracey KJ: High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 5:331–342. 2005. View Article : Google Scholar : PubMed/NCBI
4	Yamanaka S, Katayama E, Yoshioka K, Nagaki S, Yoshida M and Teraoka H: Nucleosome linker proteins HMGB1 and histone H1 differentially enhance DNA ligation reactions. Biochem Biophys Res Commun. 292:268–273. 2002. View Article : Google Scholar : PubMed/NCBI
5	Nagaki S, Yamamoto M, Yumoto Y, Shirakawa H, Yoshida M and Teraoka H: Non-histone chromosomal proteins HMG1 and 2 enhance ligation reaction of DNA double-strand breaks. Biochem Biophys Res Commun. 246:137–141. 1998. View Article : Google Scholar : PubMed/NCBI
6	Campana L, Bosurgi L and Rovere-Querini P: HMGB1: a two-headed signal regulating tumor progression and immunity. Curr Opin Immunol. 20:518–523. 2008. View Article : Google Scholar : PubMed/NCBI
7	Zhang H, Gao XS, Zhao J, et al: Differential gene expression profiles of DNA repair genes in esophageal cancer cells after X-ray irradiation. Chin J Cancer. 29:865–872. 2010. View Article : Google Scholar : PubMed/NCBI
8	Blackburn EH: Switching and signaling at the telomere. Cell. 106:661–673. 2001. View Article : Google Scholar : PubMed/NCBI
9	Kim NW, Piatyszek MA, Prowse KR, et al: Specific association of human telomerase activity with immortal cells and cancer. Science. 266:2011–2015. 1994. View Article : Google Scholar : PubMed/NCBI
10	Xiao CY, Zhou FX, Liu SQ, Xie CH, Dai J and Zhou YF: Correlations of telomere length and telomerase activity to radiosensitivity of human laryngeal squamous carcinoma cells. Ai Zheng. 24:653–656. 2005.(In Chinese). PubMed/NCBI
11	Schrumpfova PP, Fojtova M, Mokros P, Grasser KD and Fajkus J: Role of HMGB proteins in chromatin dynamics and telomere maintenance in Arabidopsis thaliana. Curr Protein Pept Sci. 12:105–111. 2011. View Article : Google Scholar : PubMed/NCBI
12	Polanska E, Dobsakova Z, Dvorackova M, Fajkus J and Stros M: HMGB1 gene knockout in mouse embryonic fibroblasts results in reduced telomerase activity and telomere dysfunction. Chromosoma. 121:419–431. 2012. View Article : Google Scholar : PubMed/NCBI
13	Yao X, Zhao G, Yang H, Hong X, Bie L and Liu G: Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma. J Cancer Res Clin Oncol. 136:677–684. 2010. View Article : Google Scholar
14	Tang T, Zhou FX, Lei H, et al: Increased expression of telomere-related proteins correlates with resistance to radiation in human laryngeal cancer cell lines. Oncol Rep. 21:1505–1509. 2009.PubMed/NCBI
15	Cawthon RM: Telomere measurement by quantitative PCR. Nucleic Acids Res. 30:e472002. View Article : Google Scholar : PubMed/NCBI
16	Jiao Y, Wang HC and Fan SJ: Growth suppression and radiosensitivity increase by HMGB1 in breast cancer. Acta Pharmacol Sin. 28:1957–1967. 2007. View Article : Google Scholar : PubMed/NCBI
17	Zhong YH, Liao ZK, Zhou FX, et al: Telomere length inversely correlates with radiosensitivity in human carcinoma cells with the same tissue background. Biochem Biophys Res Commun. 367:84–89. 2008. View Article : Google Scholar
18	Wang W, Yang L, Hu L, et al: Inhibition of UBE2D3 expression attenuates radiosensitivity of MCF-7 human breast cancer cells by increasing hTERT expression and activity. PLoS One. 8:e646602013. View Article : Google Scholar : PubMed/NCBI
19	Shimura T, Kakuda S, Ochiai Y, et al: Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3beta-mediated cyclin D1 overexpression. Oncogene. 29:4826–4837. 2010. View Article : Google Scholar : PubMed/NCBI
20	Hurley PJ and Bunz F: ATM and ATR: components of an integrated circuit. Cell Cycle. 6:414–417. 2007. View Article : Google Scholar : PubMed/NCBI
21	Rainey MD, Charlton ME, Stanton RV and Kastan MB: Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation. Cancer Res. 68:7466–7474. 2008. View Article : Google Scholar : PubMed/NCBI
22	Alao JP and Sunnerhagen P: The ATM and ATR inhibitors CGK733 and caffeine suppress cyclin D1 levels and inhibit cell proliferation. Radiat Oncol. 4:512009. View Article : Google Scholar : PubMed/NCBI
23	Gamper AM, Rofougaran R, Watkins SC, Greenberger JS, Beumer JH and Bakkenist CJ: ATR kinase activation in G1 phase facilitates the repair of ionizing radiation-induced DNA damage. Nucleic Acids Res. 41:10334–10344. 2013. View Article : Google Scholar : PubMed/NCBI
24	Qiang W, Wu Q, Zhou F, Xie C, Wu C and Zhou Y: Suppression of telomere-binding protein TPP1 resulted in telomere dysfunction and enhanced radiation sensitivity in telomerase-negative osteosarcoma cell line. Biochem Biophys Res Commun. 445:363–368. 2014. View Article : Google Scholar : PubMed/NCBI
25	O’Connor MS, Safari A, Xin H, Liu D and Songyang Z: A critical role for TPP1 and TIN2 interaction in high-order telomeric complex assembly. Proc Natl Acad Sci USA. 103:11874–11879. 2006. View Article : Google Scholar
26	Valls-Bautista C, Pinol-Felis C, Rene-Espinet JM, Buenestado-Garcia J and Vinas-Salas J: Telomeric repeat factor 1 protein levels correlates with telomere length in colorectal cancer. Rev Esp Enferm Dig. 104:530–536. 2012. View Article : Google Scholar : PubMed/NCBI
27	Li Z, Yang X, Xia N, et al: PTOP and TRF1 help enhance the radio resistance in breast cancer cell. Cancer Cell Int. 14:72014. View Article : Google Scholar : PubMed/NCBI
28	Huda N, Abe S, Gu L, Mendonca MS, Mohanty S and Gilley D: Recruitment of TRF2 to laser-induced DNA damage sites. Free Radic Biol Med. 53:1192–1197. 2012. View Article : Google Scholar : PubMed/NCBI
29	Hu L, Wu QQ, Wang WB, et al: Suppression of Ku80 correlates with radiosensitivity and telomere shortening in the U2OS telomerase-negative osteosarcoma cell line. Asian Pac J Cancer Prev. 14:795–799. 2013. View Article : Google Scholar : PubMed/NCBI
30	Celli GB and de Lange T: DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat Cell Biol. 7:712–718. 2005. View Article : Google Scholar : PubMed/NCBI
31	Smolarczyk R, Cichon T, Jarosz M and Szala S: HMGB1 - its role in tumor progression and anticancer therapy. Postepy Hig Med Dosw (Online). 66:913–920. 2012.(In Polish). View Article : Google Scholar